{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:22:55Z","timestamp":1793762575128,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ebiom.2024.105468","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T22:29:47Z","timestamp":1733264987000},"page":"105468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-5815","authenticated-orcid":false,"given":"Michael P.","family":"MacManus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennes","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed B.","family":"Sabdia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soi C.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Gunawardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Kazakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-2096","authenticated-orcid":false,"given":"Mario L.","family":"Marques-Piubelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Duenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhur","family":"Amanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Shanavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-2330","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Vajdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Hershenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Baetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodtkorb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ludvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"d\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers","family":"Blombery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-5393","authenticated-orcid":false,"given":"Maher K.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.D.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2024.105468_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105468_bib2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105468_bib3","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.28849","article-title":"Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006","volume":"135","author":"van Leeuwen","year":"2014","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105468_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","article-title":"Involved site radiation therapy in adult lymphomas: an overview of international lymphoma radiation Oncology group guidelines","volume":"107","author":"Wirth","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105468_bib5","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the first-line treatment of follicular lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105468_bib6","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1016\/S2352-3026(24)00143-1","article-title":"Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial","volume":"11","author":"Pulsoni","year":"2024","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105468_bib7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"MacManus","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.ebiom.2024.105468_bib8","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/bloodadvances.2019000458","article-title":"Outcomes of stage I\/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance","volume":"3","author":"Tobin","year":"2019","journal-title":"Blood Adv"},{"issue":"29","key":"10.1016\/j.ebiom.2024.105468_bib9","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2018.77.9892","article-title":"Randomized trial of systemic therapy after involved-field radiotherapy in patients with early-stage follicular lymphoma: TROG 99.03","volume":"36","author":"MacManus","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.ebiom.2024.105468_bib10","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1182\/bloodadvances.2022008355","article-title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared to stage III\/IV","volume":"6","author":"Los-de Vries","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105468_bib11","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41375-023-01995-w","article-title":"Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms","volume":"37","author":"Kalmbach","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105468_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.2019000560","article-title":"Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles","volume":"135","author":"Staiger","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105468_bib13","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/bjh.19698","article-title":"Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy","volume":"205","author":"Hershenfeld","year":"2024","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105468_bib14","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/bloodadvances.2020004051","article-title":"Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma","volume":"5","author":"Nath","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105468_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2020.09.015","article-title":"Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction","volume":"183","author":"Wells","year":"2020","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105468_bib16","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.ebiom.2024.105468_bib17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/bloodadvances.2016000786","article-title":"Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets","volume":"1","author":"Bolen","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105468_bib18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/2643-3230.BCD-21-0075","article-title":"Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression","volume":"3","author":"Han","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105468_bib19","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1158\/1078-0432.CCR-14-3253","article-title":"The prognostic impact of cd163-positive macrophages in follicular lymphoma: a study from the BC cancer agency and the lymphoma study association","volume":"21","author":"Kridel","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"31","key":"10.1016\/j.ebiom.2024.105468_bib20","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ebiom.2024.105468_bib21","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.02365","article-title":"Progression of disease within 24 Months in follicular lymphoma is associated with reduced intratumoral immune infiltration","author":"Tobin","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ebiom.2024.105468_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100969","article-title":"Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders","volume":"56","author":"Sabdia","year":"2022","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105468_bib23","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/s41598-019-42729-2","article-title":"A\u00a0library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients","volume":"9","author":"Koster","year":"2019","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105468_bib24","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1002\/cncr.25117","article-title":"Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy","volume":"116","author":"Campbell","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105468_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105468_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105468_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2007.09.051","article-title":"Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma","volume":"71","author":"Wirth","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105468_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2018-04-843540","article-title":"Definitive radiotherapy for localized follicular lymphoma staged by (18)F-FDG PET-CT: a collaborative study by ILROG","volume":"133","author":"Brady","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105468_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000160","article-title":"Rituximab with involved field irradiation for early-stage nodal follicular lymphoma: results of the MIR study","volume":"2","author":"Herfarth","year":"2018","journal-title":"Hemasphere"},{"key":"10.1016\/j.ebiom.2024.105468_bib30","first-page":"1","article-title":"A\u00a0cost-effectiveness analysis of front-line treatment strategies in early-stage follicular lymphoma","author":"Tobin","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105468_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","article-title":"A\u00a0gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105468_bib32","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3324\/haematol.2017.165415","article-title":"Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","volume":"102","author":"Stevens","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105468_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","article-title":"Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis","volume":"109","author":"Ame-Thomas","year":"2007","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ebiom.2024.105468_bib34","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1182\/blood.2021011362","article-title":"Discordant solutions to discordant problems","volume":"137","author":"Tobin","year":"2021","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ebiom.2024.105468_bib35","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1182\/blood.2020009855","article-title":"Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma","volume":"137","author":"Haebe","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105468_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.13574","article-title":"Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols","volume":"94","author":"de Jong","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105468_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/ejh.12075","article-title":"Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era","volume":"90","author":"Takahashi","year":"2013","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105468_bib38","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/bjh.18881","article-title":"Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen","volume":"202","author":"Laurent","year":"2023","journal-title":"Br J Haematol"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105468_bib39","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2011-04-345777","article-title":"Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study","volume":"118","author":"Laurent","year":"2011","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.ebiom.2024.105468_bib40","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105468_bib41","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/bjh.12427","article-title":"The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab","volume":"162","author":"Cheadle","year":"2013","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105468_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41408-021-00521-4","article-title":"Lack of intrafollicular memory CD4\u00a0+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma","volume":"11","author":"Mondello","year":"2021","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105468_bib43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ccell.2024.02.001","article-title":"Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients","volume":"42","author":"Radtke","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105468_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02990087","article-title":"A\u00a0British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma","volume":"11","author":"Kelsey","year":"1994","journal-title":"Med Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105468_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.blre.2004.09.001","article-title":"Follicular lymphoma: time for a re-think?","volume":"19","author":"Gandhi","year":"2005","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105468_bib46","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/imj.16454","article-title":"Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance","volume":"54","author":"Tobin","year":"2024","journal-title":"Intern Med J"},{"key":"10.1016\/j.ebiom.2024.105468_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pathol-050520-044652","article-title":"Molecular monitoring of lymphomas","volume":"18","author":"Schroers-Martin","year":"2023","journal-title":"Annu Rev Pathol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:59:03Z","timestamp":1733954343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424005048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S2352396424005048"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105468","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105468"}}